JP2010535790A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010535790A5 JP2010535790A5 JP2010520238A JP2010520238A JP2010535790A5 JP 2010535790 A5 JP2010535790 A5 JP 2010535790A5 JP 2010520238 A JP2010520238 A JP 2010520238A JP 2010520238 A JP2010520238 A JP 2010520238A JP 2010535790 A5 JP2010535790 A5 JP 2010535790A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- serotonin reuptake
- selective serotonin
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95369407P | 2007-08-03 | 2007-08-03 | |
| US60/953,694 | 2007-08-03 | ||
| PCT/US2008/072066 WO2009020897A1 (en) | 2007-08-03 | 2008-08-04 | Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine recptor ligands |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010535790A JP2010535790A (ja) | 2010-11-25 |
| JP2010535790A5 true JP2010535790A5 (enExample) | 2011-09-22 |
| JP5460594B2 JP5460594B2 (ja) | 2014-04-02 |
Family
ID=40338740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010520238A Active JP5460594B2 (ja) | 2007-08-03 | 2008-08-04 | ドーパミン受容体リガンドを含有する医薬組成物およびドーパミン受容体リガンドを用いる処置方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US20090036468A1 (enExample) |
| EP (1) | EP2185155B1 (enExample) |
| JP (1) | JP5460594B2 (enExample) |
| KR (1) | KR101612563B1 (enExample) |
| CN (1) | CN101815519B (enExample) |
| AU (1) | AU2008283989B2 (enExample) |
| CA (1) | CA2695519A1 (enExample) |
| CY (1) | CY1119828T1 (enExample) |
| DK (1) | DK2185155T3 (enExample) |
| EA (1) | EA018064B1 (enExample) |
| ES (1) | ES2653852T3 (enExample) |
| HR (1) | HRP20171908T1 (enExample) |
| HU (1) | HUE036004T2 (enExample) |
| LT (1) | LT2185155T (enExample) |
| MY (1) | MY157192A (enExample) |
| NO (1) | NO2185155T3 (enExample) |
| PL (1) | PL2185155T3 (enExample) |
| PT (1) | PT2185155T (enExample) |
| SI (1) | SI2185155T1 (enExample) |
| WO (1) | WO2009020897A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2009270823B2 (en) | 2008-07-16 | 2014-07-17 | Richter Gedeon Nyrt. | Pharmaceutical formulations containing dopamine receptor ligands |
| US20110117214A1 (en) * | 2009-11-16 | 2011-05-19 | Auspex Pharmaceuticals, Inc. | Cyclohexyl urea modulators of d2 receptors and/or d3 receptors |
| AU2011268073B2 (en) | 2010-06-18 | 2015-07-16 | Takeda Pharmaceutical Company Limited | D2 antagonists, methods of synthesis and methods of use |
| US8912197B2 (en) | 2012-08-20 | 2014-12-16 | Forest Laboratories Holdings Ltd. | Crystalline form of carbamoyl-cyclohexane derivatives |
| US11274087B2 (en) | 2016-07-08 | 2022-03-15 | Richter Gedeon Nyrt. | Industrial process for the preparation of cariprazine |
| HUP1700253A1 (hu) * | 2017-06-13 | 2019-01-28 | Richter Gedeon Nyrt | Szilárd orális gyógyszerkészítmények |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| HU231500B1 (hu) * | 2019-04-10 | 2024-04-28 | Richter Gedeon Nyrt | Karbamoil-ciklohexán származékok autizmus spektrum betegség kezelésére |
| US11547707B2 (en) | 2019-04-10 | 2023-01-10 | Richter Gedeon Nyrt. | Carbamoyl cyclohexane derivatives for treating autism spectrum disorder |
| KR20220008824A (ko) | 2019-04-17 | 2022-01-21 | 컴퍼스 패쓰파인더 리미티드 | 실로시빈으로 불안 장애, 두통 장애 및 섭식 장애를 치료하는 방법 |
| JP2024537491A (ja) * | 2021-10-28 | 2024-10-10 | アッヴィ・インコーポレイテッド | 大うつ病性障害の治療 |
| MX2024007227A (es) * | 2021-12-13 | 2024-08-20 | Compass Pathfinder Ltd | Psilocibina y un inhibidor de la recaptación de serotonina complementario para usar en el tratamiento de la depresión resistente al tratamiento. |
| CA3244202A1 (en) | 2022-03-17 | 2023-09-21 | Mapi Pharma Ltd. | DEPOSIT SYSTEMS INCLUDING CARIPRAZINE OR SALTS THEREOF |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8814057D0 (en) * | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
| ZA977967B (en) * | 1996-09-23 | 1999-03-04 | Lilly Co Eli | Combination therapy for treatment of psychoses |
| US6960577B2 (en) * | 1998-05-22 | 2005-11-01 | Eli Lilly And Company | Combination therapy for treatment of refractory depression |
| US6556540B1 (en) * | 1998-05-29 | 2003-04-29 | Paradyne Corporation | System and method for non-intrusive measurement of service quality in a communications network |
| HK1043129B (zh) * | 1999-10-25 | 2004-10-21 | H‧隆德贝克有限公司 | 西酞普蘭的製備方法 |
| UA77650C2 (en) * | 1999-12-06 | 2007-01-15 | Lundbeck & Co As H | Use of serotonin reuptake inhibitor in combination with deramcyclane |
| CA2445843A1 (en) * | 2001-05-01 | 2002-11-07 | H. Lundbeck A/S | The use of enantiomeric pure escitalopram |
| US7030122B2 (en) * | 2002-04-12 | 2006-04-18 | Sepracor Inc. | 1,4-disubstituted piperazine ligands for neurotransmitter receptors |
| AU2003240434A1 (en) * | 2002-06-20 | 2004-01-06 | H. Lundbeck A/S | Combination therapy wherein a serotinin reuptake inhibitor is used |
| HU227534B1 (en) * | 2003-08-04 | 2011-08-29 | Richter Gedeon Nyrt | (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them |
| US20070042014A1 (en) * | 2003-09-04 | 2007-02-22 | H. Lundbeck A/S | Combination of a serotonin reuptake inhibitor and loxapine |
| HUP0500170A3 (en) * | 2005-02-03 | 2007-11-28 | Richter Gedeon Nyrt | Piperazine derivatives, process for producing them and pharmaceutical compositions containing them |
| TW200812993A (en) * | 2006-05-02 | 2008-03-16 | Lundbeck & Co As H | New uses of escitalopram |
| HU230748B1 (hu) * | 2007-05-11 | 2018-02-28 | Richter Gedeon Nyrt | Új piperazin só és előállítási eljárása |
-
2008
- 2008-08-04 ES ES08782602.0T patent/ES2653852T3/es active Active
- 2008-08-04 MY MYPI2010000523A patent/MY157192A/en unknown
- 2008-08-04 WO PCT/US2008/072066 patent/WO2009020897A1/en not_active Ceased
- 2008-08-04 CN CN2008801062563A patent/CN101815519B/zh active Active
- 2008-08-04 HU HUE08782602A patent/HUE036004T2/hu unknown
- 2008-08-04 NO NO08782602A patent/NO2185155T3/no unknown
- 2008-08-04 PT PT87826020T patent/PT2185155T/pt unknown
- 2008-08-04 JP JP2010520238A patent/JP5460594B2/ja active Active
- 2008-08-04 CA CA2695519A patent/CA2695519A1/en not_active Abandoned
- 2008-08-04 EP EP08782602.0A patent/EP2185155B1/en active Active
- 2008-08-04 SI SI200831900T patent/SI2185155T1/en unknown
- 2008-08-04 HR HRP20171908TT patent/HRP20171908T1/hr unknown
- 2008-08-04 AU AU2008283989A patent/AU2008283989B2/en active Active
- 2008-08-04 EA EA201000280A patent/EA018064B1/ru unknown
- 2008-08-04 LT LTEP08782602.0T patent/LT2185155T/lt unknown
- 2008-08-04 US US12/185,211 patent/US20090036468A1/en not_active Abandoned
- 2008-08-04 KR KR1020107004638A patent/KR101612563B1/ko active Active
- 2008-08-04 PL PL08782602T patent/PL2185155T3/pl unknown
- 2008-08-04 DK DK08782602.0T patent/DK2185155T3/en active
-
2010
- 2010-09-27 US US12/890,752 patent/US20110015208A1/en not_active Abandoned
-
2011
- 2011-10-10 US US13/269,928 patent/US20120028991A1/en not_active Abandoned
-
2017
- 2017-12-07 CY CY20171101293T patent/CY1119828T1/el unknown